Shots:

• The companies collaborate to advance the discovery of novel biomarkers & drug targets using spatial imaging & ML technologies
• The collaboration combines NanoString’s GeoMx DSP spatial biology platforms with Visiopharm’s AI-driven image analysis capabilities to enable integrated workflows for translational research studies. NanoString’s AtoMx Spatial Informatics Platform will improve integration by delivering scalable computing power with global access
• The technologies will advance biomarker development & validation through in situ whole transcriptome & high-plex protein analysis. By incorporating Visiopharm's Oncotopix Discovery software into GeoMx DSP workflow, sample processing for translational research applications will enhance & simplified

Ref: Businesswire | Image: NanoString